This federal contract award, with ID 75N95019P00175, was made by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Acea Biosciences, Inc. for the purchase of one (1) ACEA Novocyte Quanteon flow cytometer system with a Novosampler Q package. The $175,000.00 firm fixed-price purchase order did not utilize any set-aside designations.
The original solicitation was a non-competitive pre-solicitation notice issued under simplified acquisition procedures, as NIDA determined Acea Biosciences was the sole source capable of meeting the government's requirement for a benchtop flow cytometer system with specific salient characteristics. This specialized laboratory instrument will support research efforts at NIDA, which is the lead agency within NIH for research on drug use and addiction. Acea Biosciences is a subsidiary of the larger life sciences instrumentation provider Agilent Technologies, Inc., which has an extensive history of federal contract awards for analytical equipment and services across various government agencies.